ProKidney (PROK)
NASDAQ:PROK
Total Valuation
ProKidney has a market cap or net worth of $573.64M. The enterprise value is $444.51M.
Market Cap$573.64M
Enterprise Value$444.51M
Share Statistics
ProKidney has 141,942,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding141,942,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
ProKidney’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is -54.13%.
Return on Equity (ROE)0.07
Return on Assets (ROA)-0.21
Return on Invested Capital (ROIC)-54.13%
Return on Capital Employed (ROCE)-0.54
Revenue Per Employee4.38K
Profits Per Employee-743.20K
Employee Count204
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of ProKidney is ―. ProKidney’s PEG ratio is 0.27.
PE Ratio―
PS Ratio335.98
PB Ratio-0.30
Price to Fair Value-0.30
Price to FCF-2.22
Price to Operating Cash Flow-2.14
PEG Ratio0.27
Income Statement
In the last 12 months, ProKidney had revenue of 893.00K and earned -68.99M in profits. Earnings per share was -0.52.
Revenue893.00K
Gross Profit-4.83M
Operating Income-165.01M
Pretax Income-151.20M
Net Income-68.99M
EBITDA-158.97M
Earnings Per Share (EPS)-0.52
Cash Flow
In the last 12 months, operating cash flow was -120.12M and capital expenditures -15.20M, giving a free cash flow of -135.31M billion.
Operating Cash Flow-120.12M
Free Cash Flow-135.31M
Free Cash Flow per Share-0.95
Dividends & Yields
ProKidney pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.27
52-Week Price Change222.03%
50-Day Moving Average2.07
200-Day Moving Average2.39
Relative Strength Index (RSI)46.23
Average Volume (3m)748.09K
Important Dates
ProKidney upcoming earnings date is May 8, 2026, After Close (Confirmed).
Last Earnings DateMar 18, 2026
Next Earnings DateMay 8, 2026
Ex-Dividend Date―
Financial Position
ProKidney as a current ratio of 9.13, with Debt / Equity ratio of -0.29%
Current Ratio9.13
Quick Ratio9.13
Debt to Market Cap0.00
Net Debt to EBITDA0.66
Interest Coverage Ratio-41.25K
Taxes
In the past 12 months, ProKidney has paid 414.00K in taxes.
Income Tax414.00K
Effective Tax Rate>-0.01
Enterprise Valuation
ProKidney EV to EBITDA ratio is -3.62, with an EV/FCF ratio of -4.25.
EV to Sales644.27
EV to EBITDA-3.62
EV to Free Cash Flow-4.25
EV to Operating Cash Flow-4.79
Balance Sheet
ProKidney has $270.02M in cash and marketable securities with $2.96M in debt, giving a net cash position of $267.05M billion.
Cash & Marketable Securities$270.02M
Total Debt$2.96M
Net Cash$267.05M
Net Cash Per Share$1.88
Tangible Book Value Per Share$2.25
Margins
Gross margin is -218.81%, with operating margin of -18477.83%, and net profit margin of -7725.20%.
Gross Margin-218.81%
Operating Margin-18477.83%
Pretax Margin-16931.47%
Net Profit Margin-7725.20%
EBITDA Margin-17801.46%
EBIT Margin-18442.22%
Analyst Forecast
The average price target for ProKidney is $7.33, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$7.33
Price Target Upside285.79% Upside
Analyst ConsensusHold
Analyst Count5
Revenue Growth Forecast―
EPS Growth Forecast2.35%